510(k) clearance K211044 for Creagh Medical Ltd. (A Wholly Owned Subsidiary of Surmodics,. View source facts, labeled dates, and the original FDA record.
Creagh Medical Ltd. (A Wholly Owned Subsidiary of Surmodics,
FDA decision date
Jun 16, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Decision stated in the source
Substantially Equivalent
Source facts
Decision
Substantially Equivalent
Received
2021-04-08
Specialty
Cardiovascular
Decision code
SESE
Clearance type
Special
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.